Chesapeake Asset Management’s Labcorp LH Stock Holding History

Chesapeake Asset Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.2K	Buy	+15	New	+$3.94K	﹤0.01%	295

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Chesapeake Asset Management's LH Position: Q2 2026 in Review

Chesapeake Asset Management opened a new position in Labcorp (LH) in Q2 2026: 15 shares worth $4.2K. The stake represents ﹤0.01% of the portfolio and ranks #295 among its holdings.

1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Chesapeake Asset Management held 15 shares of Labcorp worth $4.2K as of Q2 2026.
Labcorp was a new Chesapeake Asset Management position in Q2 2026.
Labcorp made up ﹤0.01% of Chesapeake Asset Management's portfolio in Q2 2026, its #295 holding.
1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.